Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-01-27

Clinical Trial Update: Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of omega-3 fish oil in overweight children and adolescents has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 Fish Oil (omega-3 fatty acids)

Snippet

Sponsor: Children's Heart Center | Conditions: Overweight, Obesity | Phase 3 | Status: TERMINATED